EU member states start vaccination
All EU countries have access to the vaccine at the same time, and more vaccines will arrive soon, by which people can gradually return to normal life.
The BioNTech Pfizer vaccine was the first that got approval from the European Medicines Agency (EMA), the EU's medicines regulator.
The EMA is currently assessing the vaccine from American drug maker Moderna and is expected to make a decision on the vaccine in the first week of January.
The EU Commission has neither disclosed how many doses of the vaccine have been distributed to member states so far, nor confirmed how many vaccines have been sent to which country. But for now, the number of doses is quite small due to limited production.
The EU Commission, on behalf of all member states, has so far signed contracts with six companies to purchase a total of two billion doses of vaccines.
The Union will receive 400 million doses of the vaccine from AstraZeneca, 300 million from Sanofi-GSK, 400 million from Johnson and Johnson, 300 million from Pfizer and BioNTech, 405 million from CureVac and 160 million from Moderna.
Novavax has also reached the contract stage for 200 million doses. With the signing of this agreement, the number of doses the EU can take will reach 2.2 billion.
Each EU country will determine who will be given priority, and there is no common EU decision or recommendation on this issue.
While new restrictions are imposed ahead of the holiday season, especially across Europe, countries are approving and procuring vaccines to end the pandemic. ■